tesaglitazar regulates glucose lowering

Subject: tesaglitazar
Relation: regulates
Object: glucose lowering
p-value: —

Evidence from: primary | all sources

Evidence (1 sources)

The PPAR α / γ Agonist, Tesaglitazar, Improves Insulin Mediated Switching of Tissue Glucose and Free Fatty Acid Utilization In Vivo in the Obese Zucker Rat. (2013) PMID:24285952 cited

approximately 6 weeks of treatment is required for tesaglitazar to achieve the full glucose lowering effect

confidence: 0.90